Clinical trial
A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode
NCT01917487 is registered in ClinicalTrials.gov with OrSense, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode
- Lead sponsor
- OrSense, Ltd.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2011
- Completion date
- November 30, 2013
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.